ATE338762T1 - Zusammensetzungen und methoden für die verknüpfung von endothelzellen - Google Patents

Zusammensetzungen und methoden für die verknüpfung von endothelzellen

Info

Publication number
ATE338762T1
ATE338762T1 AT92911299T AT92911299T ATE338762T1 AT E338762 T1 ATE338762 T1 AT E338762T1 AT 92911299 T AT92911299 T AT 92911299T AT 92911299 T AT92911299 T AT 92911299T AT E338762 T1 ATE338762 T1 AT E338762T1
Authority
AT
Austria
Prior art keywords
sialyl
methods
compositions
endothelial cells
present
Prior art date
Application number
AT92911299T
Other languages
English (en)
Inventor
John L Magnani
Eugene C Butcher
Ellen L Berg
Original Assignee
Univ Leland Stanford Junior
John L Magnani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, John L Magnani filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE338762T1 publication Critical patent/ATE338762T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92911299T 1991-04-19 1992-04-17 Zusammensetzungen und methoden für die verknüpfung von endothelzellen ATE338762T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68803791A 1991-04-19 1991-04-19
US72177191A 1991-06-25 1991-06-25
US72116091A 1991-06-26 1991-06-26

Publications (1)

Publication Number Publication Date
ATE338762T1 true ATE338762T1 (de) 2006-09-15

Family

ID=27418500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911299T ATE338762T1 (de) 1991-04-19 1992-04-17 Zusammensetzungen und methoden für die verknüpfung von endothelzellen

Country Status (7)

Country Link
EP (1) EP0580763B1 (de)
JP (1) JPH0826045B2 (de)
AT (1) ATE338762T1 (de)
AU (1) AU1926692A (de)
CA (1) CA2108786A1 (de)
DE (1) DE69233654D1 (de)
WO (1) WO1992018610A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
WO1992008490A1 (en) * 1990-11-16 1992-05-29 The Board Of Trustees Of The Leland Stanford Junior University Skin-associated lymphocytes and markers
IE914075A1 (en) * 1990-11-23 1992-06-03 Gen Hospital Corp Inhibition of cell adhesion protein-carbohydrate¹interactions
EP0668871A1 (de) * 1991-05-03 1995-08-30 The Rockefeller University Homologien in der aminosaüre-sequenz zwischen peptiden der selectine und peptiden des b.pertussis-toxin, antikörper dagegen und pharmazeutische verbindungen
WO1993005803A1 (en) * 1991-09-25 1993-04-01 Genetics Institute, Inc. Anti-inflammatory selectin inhibitors
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
US5643873A (en) * 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5728802A (en) * 1992-05-06 1998-03-17 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
US5648458A (en) * 1992-05-06 1997-07-15 Affymax Technologies N.V. Peptides and compounds that bind to ELAM-1
GB9300989D0 (en) * 1993-01-19 1993-03-10 British Bio Technology Disaccharide ligands
CA2157489A1 (en) * 1993-03-04 1994-09-15 Masaaki Numata Lewis-associated compound, process for producing the same, and anti-inflammatory
US5789385A (en) * 1993-06-16 1998-08-04 Glycomed Incorporated Sialyl Lewisx mimetics containing phenyl backbones
US5658880A (en) * 1993-06-16 1997-08-19 Glycomed Incorporated Sialic acid/fucose based medicaments
US5750508A (en) * 1993-06-16 1998-05-12 Glycomed Incorporated Sialic acid/fucose based medicaments
US5837689A (en) * 1993-06-16 1998-11-17 Glycomed Incorporated Sialyl lewis-x mimetics containing naphthyl backbones
US5679321A (en) * 1993-06-17 1997-10-21 Glycomed Incorporated Sialic acid/fucose based medicaments
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
EP0671409A3 (de) * 1994-03-11 1996-06-12 Hoechst Ag Malonsäurederivate mit antiadhäsiven Eigenschaften.
EP1428832A3 (de) * 1995-08-03 2004-09-22 The Board of Regents for the University of Oklahoma Peptid-und O-Glycaninhibitoren von Selectin vermittelten Entzündungen
KR19980703698A (ko) * 1996-02-08 1998-12-05 모리따 겐조 암 전이 억제 항암제 물질
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤
JP5766947B2 (ja) 2007-09-07 2015-08-19 チルドレンズ ホスピタル メディカル センター 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
DK2451462T3 (en) 2009-07-06 2017-12-11 Children's Hospital Medical Center Inhibition of inflammation with milk oligosaccharides
WO2014130789A1 (en) 2013-02-21 2014-08-28 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
EP3578983A4 (de) * 2017-02-03 2020-12-09 Sumitomo Chemical Company, Limited Verfahren zur erkennung von bauchspeicheldrüsenkrebs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851511A (en) * 1986-01-30 1989-07-25 Fred Hutchinson Cancer Research Center Monoclonal antibody that specifically binds to disialosyl Lea
EP0381310A1 (de) * 1989-01-30 1990-08-08 The Biomembrane Institute Monoklonale Antikörper gegen Tumor-assoziierte Ganglioside und Fucoganglioside sowie Produktionsmethode
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
EP0408859B1 (de) * 1989-05-23 1995-08-09 Otsuka Pharmaceutical Co., Ltd. Monoklonale Antikörper gegen aktivierte endotheliale Zellen
AU8007791A (en) * 1990-06-15 1992-01-07 Cytel Corporation Intercellular adhesion mediators
ATE224911T1 (de) * 1990-07-17 2002-10-15 Univ Oklahoma Gmp-140 ligand
NZ240316A (en) * 1990-10-25 1996-12-20 Univ Michigan Compound for treating disease mediated by the elaboration of elam-1 on endothelial cells

Also Published As

Publication number Publication date
WO1992018610A2 (en) 1992-10-29
EP0580763B1 (de) 2006-09-06
AU1926692A (en) 1992-11-17
JPH0826045B2 (ja) 1996-03-13
DE69233654D1 (de) 2006-10-19
EP0580763A1 (de) 1994-02-02
JPH06507927A (ja) 1994-09-08
WO1992018610A3 (en) 1993-04-01
CA2108786A1 (en) 1992-10-20

Similar Documents

Publication Publication Date Title
ATE338762T1 (de) Zusammensetzungen und methoden für die verknüpfung von endothelzellen
Eckhardt et al. Isolation and characterization of a family of. alpha.-D-galactosyl-containing glycopeptides from Ehrlich ascites tumor cells
Kornfeld et al. Solubilization and partial characterization of a phytohemagglutinin receptor site from human erythrocytes
DE58906377D1 (en) Difluormethylverbindungen.
DE69739120D1 (en) Staphylococcus aureus antigen
FR2641540B1 (de)
ES8607387A1 (es) Un metodo de produccion de un acido nucleico inmovilizado.
DE69228159D1 (de) Glasverstärkte gepfropft-verzweigte höhere alpha-olefine
BR9711117A (pt) Oligossacarídios modificados.
AU3498893A (en) 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
DE69619808T2 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
CA2159330A1 (en) Inhibition of leukocyte adhesion
Hunáková et al. Tyrosine kinase inhibitor-induced differentiation of K-562 cells: alterations of cell cycle and cell surface phenotype
FI853095L (fi) Foerfarande foer aotervinning av en gelbildande polysackarid, aotervunnen polysackarid och gel bildad daermed.
EA199900256A1 (ru) Нуклеотидная и белковая последовательность маммастатина и способы применения
SE9402027D0 (sv) Energy substrates
FI931086A0 (fi) Foerfarande foer framstaellning av kolhydrater
IL105064A0 (en) Glycosylation-mediated inhibition of factor x
Aizawa et al. Antitumor effect of a baker's yeast mannan—mitomycin C conjugate against mouse hepatoma, MH134, in vivo and in vitro
Lang et al. Molecular identification of lectin binding sites differentiating related low and high metastatic murine lymphomas
CA2222718A1 (en) Attachment enhanced 293 cells
AU6617896A (en) Cardiac tropism radiopharmaceutical products incorporating a nitride complex of a transition metal and having a rapid myocardial clearance
CHUA AN INVESTIGATION ON THE SURFACE PROPERTIES OF EMBRYONAL CARCINOMA CELLS: FUNCTIONAL AND STRUCTURAL CORRELATIONS TO EARLY EMBRYOS (GLYCOPROTEINS, PREIMPLANTATION, MOUSE)
SE8604090D0 (sv) Recovery of gold using diisobutyl and disec butyl monothiophosphinates
ITIM970003A0 (it) Liquore infuso di polpa di fico d'india.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties